X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (30030) 30030
Book Review (3846) 3846
Publication (2812) 2812
Newsletter (419) 419
Book Chapter (185) 185
Conference Proceeding (83) 83
Book / eBook (42) 42
Dissertation (36) 36
Magazine Article (11) 11
Newspaper Article (9) 9
Web Resource (7) 7
Streaming Video (6) 6
Data Set (4) 4
Government Document (1) 1
Paper (1) 1
Reference (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (27946) 27946
humans (16112) 16112
animals (13099) 13099
cytochrome p-450 enzyme system - genetics (12383) 12383
cytochrome p-450 enzyme system - metabolism (9920) 9920
male (9712) 9712
cytochrome p-450 (8405) 8405
female (7883) 7883
pharmacology & pharmacy (7004) 7004
biochemistry & molecular biology (5249) 5249
metabolism (4868) 4868
rats (4670) 4670
cytochrome p450 (4609) 4609
enzymes (4139) 4139
physiological aspects (3822) 3822
mice (3797) 3797
toxicology (3757) 3757
expression (3695) 3695
adult (3647) 3647
analysis (3609) 3609
genotype (3515) 3515
middle aged (3431) 3431
gene expression (3358) 3358
molecular sequence data (3262) 3262
genes (3052) 3052
genetic aspects (3052) 3052
research (2905) 2905
liver (2624) 2624
base sequence (2606) 2606
polymorphism, genetic (2545) 2545
liver - enzymology (2311) 2311
amino acid sequence (2242) 2242
aged (2210) 2210
cytochrome p-450 enzyme system - biosynthesis (2173) 2173
rna, messenger - metabolism (2092) 2092
pharmacogenetics (2064) 2064
pharmacokinetics (2042) 2042
liver - metabolism (1966) 1966
mixed function oxygenases - genetics (1857) 1857
mutation (1820) 1820
hydroxylation (1816) 1816
microsomes, liver - enzymology (1767) 1767
proteins (1764) 1764
induction (1749) 1749
liver - drug effects (1743) 1743
aryl hydrocarbon hydroxylases - genetics (1742) 1742
in-vitro (1715) 1715
metabolites (1713) 1713
phenotype (1693) 1693
cytochrome (1685) 1685
kinetics (1680) 1680
rna, messenger - genetics (1671) 1671
polymorphism (1668) 1668
aryl hydrocarbon hydroxylases (1666) 1666
genetic research (1664) 1664
cytochrome p-450 enzyme system - chemistry (1657) 1657
gene-expression (1628) 1628
genetics & heredity (1625) 1625
dose-response relationship, drug (1600) 1600
identification (1597) 1597
oncology (1562) 1562
polymerase chain reaction (1558) 1558
cytochrome p-450 cyp3a (1556) 1556
article (1550) 1550
cells, cultured (1548) 1548
cancer (1529) 1529
alleles (1521) 1521
mixed function oxygenases - metabolism (1488) 1488
cell biology (1482) 1482
cloning, molecular (1457) 1457
biotransformation (1436) 1436
drug interactions (1424) 1424
cytochrome p-450 cyp1a1 - genetics (1386) 1386
gene (1349) 1349
genetic polymorphisms (1319) 1319
biotechnology & applied microbiology (1295) 1295
endocrinology & metabolism (1289) 1289
rats, sprague-dawley (1284) 1284
cell line (1267) 1267
multidisciplinary sciences (1256) 1256
research article (1239) 1239
abridged index medicus (1234) 1234
health aspects (1226) 1226
oxidation-reduction (1222) 1222
oxidative stress (1213) 1213
risk factors (1202) 1202
biosynthesis (1200) 1200
polymorphism, single nucleotide (1198) 1198
substrate specificity (1183) 1183
reverse transcriptase polymerase chain reaction (1168) 1168
cytochrome p-450 cyp1a1 - metabolism (1152) 1152
genetics (1144) 1144
biophysics (1129) 1129
microsomes, liver - metabolism (1124) 1124
cytochrome p-450 enzyme inhibitors (1109) 1109
cytochrome p-450 cyp2d6 - genetics (1106) 1106
enzyme induction (1101) 1101
medicine (1092) 1092
rna (1086) 1086
toxicity (1076) 1076
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (30042) 30042
Japanese (133) 133
Chinese (121) 121
Russian (77) 77
French (58) 58
German (49) 49
Polish (35) 35
Spanish (25) 25
Danish (12) 12
Swedish (10) 10
Norwegian (9) 9
Italian (7) 7
Czech (5) 5
Finnish (4) 4
Dutch (2) 2
Hungarian (2) 2
Korean (2) 2
Portuguese (2) 2
Romanian (2) 2
Slovak (2) 2
Hebrew (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Drug Metabolism and Disposition, ISSN 0090-9556, 01/2010, Volume 38, Issue 1, pp. 92 - 99
The aim of the current study is to identify the human cytochrome P450 (P450) isoforms involved in the two oxidative steps in the bioactivation of clopidogrel... 
MECHANISM-BASED INHIBITION | ANTIAGGREGATING ACTIVITY | POLYMORPHISMS | TICLOPIDINE | PHARMACOKINETICS | HEALTHY-SUBJECTS | PHARMACOLOGY & PHARMACY | PRASUGREL | PHARMACODYNAMICS | MONOCLONAL-ANTIBODIES | ATORVASTATIN | Microsomes - metabolism | Humans | Aryl Hydrocarbon Hydroxylases - genetics | Cytochrome P-450 Enzyme System - metabolism | Sulfaphenazole - pharmacology | Microsomes - drug effects | Cytochrome P-450 CYP3A - genetics | Cytochrome P-450 CYP1A2 - genetics | Antibodies - immunology | Omeprazole - pharmacology | Microsomes, Liver - enzymology | Platelet Aggregation Inhibitors - pharmacokinetics | Ticlopidine - pharmacokinetics | Oxidoreductases, N-Demethylating - metabolism | Aryl Hydrocarbon Hydroxylases - immunology | Oxidation-Reduction | Enzyme Inhibitors - pharmacology | Ticlopidine - analogs & derivatives | Oxidoreductases, N-Demethylating - immunology | Cytochrome P-450 CYP3A - metabolism | Cell Line, Tumor | Cytochrome P-450 Enzyme System - genetics | Theophylline - pharmacology | Kinetics | Cytochrome P-450 CYP2C9 | Theophylline - analogs & derivatives | Oxidoreductases, N-Demethylating - genetics | Glutathione - metabolism | Ketoconazole - pharmacology | Biotransformation - physiology | Cytochrome P-450 CYP1A2 Inhibitors | Microsomes, Liver - drug effects | Ticlopidine - metabolism | NADP - metabolism | Platelet Aggregation Inhibitors - metabolism | Cytochrome P-450 CYP3A - immunology | Cell Line | Aryl Hydrocarbon Hydroxylases - antagonists & inhibitors | Cytochrome P-450 CYP1A2 - immunology | Biocatalysis | Mephenytoin - analogs & derivatives | Cytochrome P-450 CYP1A2 - metabolism | Aryl Hydrocarbon Hydroxylases - metabolism | Mephenytoin - pharmacology | Antibodies - pharmacology | Cytochrome P-450 CYP3A Inhibitors | Cytochrome P-450 CYP2C19 | Clopidogrel | Cytochrome P-450 CYP2B6 | Index Medicus
Journal Article
Journal Article
International Journal of Nanomedicine, ISSN 1176-9114, 2018, Volume 13, pp. 8561 - 8575
Introduction and objective: Currently, carbon nanostructures are vastly explored materials with potential for future employment in biomedicine. The possibility... 
Nanoparticles | Carbon nanostructures | Cytochrome p450 | Liver | Microsomes | liver | POLYCYCLIC AROMATIC-HYDROCARBONS | NANOMATERIALS | NANOSCIENCE & NANOTECHNOLOGY | TOXICITY | carbon nanostructures | cytochrome P450 | INDUCTION | DRUG-METABOLIZING-ENZYMES | WALLED CARBON NANOTUBES | nanoparticles | HEPG2 CELLS | PHARMACOLOGY & PHARMACY | EXPRESSION | CYTOCHROME-P450 ENZYME | microsomes | Cytochrome P-450 CYP2D6 - genetics | Nanostructures - ultrastructure | Cytochrome P-450 Enzyme Inhibitors | Cell Survival | Humans | Liver - metabolism | Cytochrome P-450 Enzyme System - metabolism | Fluorescence | Hydrodynamics | Hepatocytes - metabolism | Diamond - chemistry | Cytochrome P-450 CYP1A2 - metabolism | Down-Regulation - genetics | Hep G2 Cells | Cytochrome P-450 CYP3A - genetics | Cytochrome P-450 CYP3A - metabolism | Isoenzymes - metabolism | Cytochrome P-450 CYP1A2 - genetics | Cytochrome P-450 CYP2D6 - metabolism | Cytochrome P-450 Enzyme System - genetics | Nanostructures - chemistry | Graphite - chemistry | Cytochrome P-450 Enzyme System - pharmacology | Hepatocytes - drug effects | Diamond crystals | RNA | Isoenzymes | Graphene | Genes | Cytochrome P-450 | Diamonds | Graphite | Genetic research | Genetic aspects | Gene expression | Cytochrome | Enzymes | Drug delivery systems | Nanomaterials | Metabolism | Carbon | Drug dosages | Index Medicus
Journal Article
Basic & Clinical Pharmacology & Toxicology, ISSN 1742-7835, 09/2016, Volume 119, Issue 3, pp. 284 - 290
Cytochrome P450 ( CYP ) activity can be assessed using a ‘cocktail’ phenotyping approach. Recently, we have developed a cocktail (Geneva cocktail) which... 
2D6 | PARAXANTHINE | BUPROPION | IN-VIVO | PHARMACOLOGY & PHARMACY | TOXICOLOGY | FLURBIPROFEN | METABOLIZING-ENZYMES | COOPERSTOWN 5+1 COCKTAIL | ORAL-CONTRACEPTIVES | P-GLYCOPROTEIN | Caffeine - administration & dosage | Humans | Midazolam - administration & dosage | Male | Genotyping Techniques | Cytochrome P-450 CYP2B6 - metabolism | Terfenadine - administration & dosage | Caffeine - pharmacokinetics | Dose-Response Relationship, Drug | Young Adult | Drug Interactions | Cytochrome P-450 CYP3A - genetics | Dried Blood Spot Testing - methods | Cytochrome P-450 CYP1A2 - genetics | Flurbiprofen - administration & dosage | Adult | Female | Dextromethorphan - pharmacokinetics | Cytochrome P-450 CYP2C9 - metabolism | Terfenadine - pharmacokinetics | Bupropion - pharmacokinetics | Cytochrome P-450 CYP2D6 - genetics | Flurbiprofen - pharmacokinetics | Cytochrome P-450 CYP2B6 - genetics | Omeprazole - administration & dosage | Cytochrome P-450 CYP2C19 - genetics | Terfenadine - analogs & derivatives | Omeprazole - pharmacokinetics | Midazolam - pharmacokinetics | Cytochrome P-450 CYP1A2 - metabolism | Bupropion - administration & dosage | Cytochrome P-450 CYP2C9 - genetics | Cross-Over Studies | Phenotype | Cytochrome P-450 CYP3A - metabolism | Adolescent | Cytochrome P-450 CYP2D6 - metabolism | Cytochrome P-450 Enzyme System - genetics | Cytochrome P-450 CYP2C19 - metabolism | Dextromethorphan - administration & dosage | Medical examination | Drug interactions | Analysis | Methods | Blood | Cytochrome P-450 | Confidence intervals | Cytochrome | Prescription drugs | Drug dosages | Index Medicus
Journal Article
Journal Article
Drug Metabolism and Disposition, ISSN 0090-9556, 03/2010, Volume 38, Issue 3, pp. 448 - 458
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2014, Volume 9, Issue 4, pp. e93261 - e93261
Intratumoral expression of genes encoding Cytochrome P450 enzymes (CYP) might play a critical role not only in cancer development but also in the metabolism of... 
PEDIATRIC RHABDOMYOSARCOMA | CYP2W1 | THERAPY | METABOLISM | MULTIDISCIPLINARY SCIENCES | SARCOMA | PREVENTION | CYP3A4/5 | CYP1B1 | CANCER | CHILDREN | Cytochrome P-450 CYP1A1 - genetics | Cytochrome P-450 CYP1B1 - genetics | Prospective Studies | Follow-Up Studies | Humans | Rhabdomyosarcoma - metabolism | Gene Expression Regulation, Neoplastic | Child, Preschool | Cytochrome P-450 Enzyme System - metabolism | Cytochrome P-450 CYP1B1 - metabolism | Infant | Male | Muscle, Skeletal - metabolism | Cytochrome P-450 CYP2E1 - genetics | Gene Expression Profiling | Cytochrome P-450 CYP2E1 - metabolism | Cytochrome P450 Family 2 | Cytochrome P-450 CYP3A - genetics | Cytochrome P-450 CYP1A2 - genetics | Biomarkers, Tumor - metabolism | Female | Child | Real-Time Polymerase Chain Reaction | RNA, Messenger - genetics | Cytochrome P-450 CYP1A1 - metabolism | Reverse Transcriptase Polymerase Chain Reaction | Cytochrome P-450 CYP1A2 - metabolism | Blotting, Western | Gene Expression Regulation, Enzymologic | Cytochrome P-450 CYP3A - metabolism | Adolescent | Cytochrome P-450 Enzyme System - genetics | Biomarkers, Tumor - genetics | Rhabdomyosarcoma - genetics | Cytochrome | Drugs | Rhabdomyosarcoma | Chemoresistance | Families & family life | Drug development | Tissues | Cancer therapies | Antitumor agents | Rodents | Drug metabolism | Children | Enzymes | Prodrugs | Cytochrome P450 | CYP gene | CYP1A2 protein | Metabolism | Gene expression | Chemical compounds | Patients | Polymerase chain reaction | Musculoskeletal system | Chemotherapy | Tumors | Cancer | Index Medicus
Journal Article
Circulation, ISSN 0009-7322, 05/2009, Volume 119, Issue 19, pp. 2553 - 2560
Background-Both clopidogrel and prasugrel require biotransformation to active metabolites by cytochrome P450 (CYP) enzymes. Among persons treated with... 
Drugs | Cardiovascular diseases | Genetics | 2007 FOCUSED UPDATE | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | drugs | STENT THROMBOSIS | HEALTHY-SUBJECTS | OF-FUNCTION POLYMORPHISM | cardiovascular diseases | PERCUTANEOUS CORONARY INTERVENTION | genetics | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | THIENOPYRIDINE ANTIPLATELET AGENT | PLATELET REACTIVITY | CLOPIDOGREL RESPONSIVENESS | ACTIVE METABOLITE | Prasugrel Hydrochloride | Thiophenes - therapeutic use | Myocardial Infarction - mortality | Cardiovascular Diseases - drug therapy | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Aryl Hydrocarbon Hydroxylases - genetics | Biotransformation - genetics | Cytochrome P-450 Enzyme System - metabolism | Male | Young Adult | Receptors, Purinergic P2Y12 | Cardiovascular Diseases - mortality | Platelet Aggregation Inhibitors - pharmacology | Adult | Female | Microsomes, Liver - enzymology | Platelet Aggregation - drug effects | Platelet Aggregation Inhibitors - pharmacokinetics | Piperazines - pharmacokinetics | Stroke - mortality | Platelet Aggregation Inhibitors - therapeutic use | Stroke - prevention & control | Purinergic P2 Receptor Antagonists | Thiophenes - pharmacology | Genotype | Treatment Outcome | Piperazines - therapeutic use | Piperazines - pharmacology | Aryl Hydrocarbon Hydroxylases - metabolism | Polymorphism, Genetic | Thiophenes - pharmacokinetics | Prodrugs - pharmacokinetics | Cytochrome P-450 CYP2C19 | Cytochrome P-450 Enzyme System - genetics | Aged | Myocardial Infarction - prevention & control | Prodrugs - therapeutic use | Prodrugs - pharmacology | Care and treatment | Demographic aspects | Patient outcomes | Cytochrome P-450 | Genetic aspects | Research | Genetic polymorphisms | Heart attack | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article